Author:
Li Qianxi,Ling Yulin,Chen Guanxu,Ye Shangqiu
Reference39 articles.
1. D.M. Cutler, L.H. Summers, The COVID-19 Pandemic and the $16 Trillion Virus, JAMA. Oct 20;324(15):1495-1496. doi: 10.1001/jama.2020.19759.
2. P.V. Markov, M. Ghafari, M. Beer, K. Lythgoe, P. Simmonds, N.I. Stilianakis, A. Katzourakis, The evolution of SARS-CoV-2, Nat Rev Microbiol. Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2.
3. N.G. Davies, S. Abbott, R.C. Barnard, C.I. Jarvis, A.J. Kucharski, J.D. Munday, et al., Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England, Science. Apr 9;372(6538). doi: 10.1126/science.abg3055.
4. N. Haug, L. Geyrhofer, A. Londei, E. Dervic, A. Desvars-Larrive, V. Loreto, et al., Ranking the effectiveness of worldwide COVID-19 government interventions, Nat Hum Behav. Dec;4(12):1303-1312. doi: 10.1038/s41562-020-01009-0.
5. World Health Organization, Prioritizing diseases for research and development in emergency contexts. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts, (accessed 2024/3/28).